Monday, December 30, 2024

World's Snakebite Capital Slithers Into Action

Snakebite Capital Slithers Into Action
View in browser
Bloomberg

Prognosis is now exclusively for Bloomberg.com subscribers. As a loyal reader, we'll keep sending it to you for a limited time. If you'd like to continue receiving Prognosis, and gain unlimited digital access to all of Bloomberg.com, we invite you to subscribe now at the special rate of $129 for your first year (usually $299).

Hi, it's Satviki in Mumbai, where the end of the year saw India's administration move toward reducing mortality from snakebites. But before we get into that...

Today's must-reads

Venomous snakes

The World Health Organization estimates that about 5 million snakebites occur each year, with as many as 2.7 million cases involving venomous snakes. Reports suggest that between 81,000 and 138,000 people die each year globally as a result, with roughly half of all deaths occurring in India.

Around 90% of snakebites in India are caused by the 'big four' among the crawlers — common krait, Indian cobra, Russell's viper and saw scaled viper. The majority of cases occur in villages as farmers work in fields, with little awareness of dealing with the reptiles, according to the Tropical Institute of Ecological Sciences.

A Cobra, from left, saw scaled viper, Krait and Russell's viper displayed at venom extraction center in Chennai, India. Photographer: Arun Sankar/AFP/Getty Images

Although highly effective treatments exist in the form of antivenoms, many cases go unreported or untreated — making snakebites a neglected public health issue in the world's most-populous nation.

While antivenoms are included in the WHO Essential Medicines List and should be part of any primary health-care package where snake bites occur, the lack of data leads to under-estimation of antivenom needs by health authorities, driving down demand for manufacturers to produce antivenom products, according to WHO.

But in November, the federal health ministry asked Indian states to classify snakebites as a 'notifiable disease,' in turn making it compulsory for all government and private healthcare centers to report all suspected cases and deaths to local governments. That will aid in data collection and accelerate public health efforts in curbing the poisoning.

Venom is extracted from a cobra. Photographer: Arun Sankar/AFP/Getty Images

"Making it a notifiable disease is something we've been working on for a long, long time," said Romulus Whitaker, an American-born Indian herpetologist.

"Not that much effort has gone into controlling and preventing snakebite because governments didn't realize how big the issue was," said the 81-year-old Whitaker, who's authored a study on snakebite mortality. "The health authorities are guided by statistics."

With the latest notification, data should start pouring in and will likely aid authorities in dealing with the disease and ensure availability of anti-venom in local health centers as well as paramedics who can administer the required treatment.

The notification — along with a national action plan launched in March to deal with snakebite poisoning — will support WHO's target of halving global deaths and disabilities by 2030.

A Russell's viper snake stuck under a tractor in a field in the outskirts of Bangalore. Photographer: Manjunath Kiran/AFP/Getty Images

Despite the optimism brought by the health ministry's move, educating and training farmers — the most affected population — to identify the four deadly snakes remains a key issue for India, nicknamed 'Snakebite capital of the world.'

"It is about being able to identify the snakes, getting people to understand snakes' habits and how to avoid them," Whitaker said. — Satviki Sanjay

What we're reading

A wide range of diseases and conditions can be eliminated, WHO says in its 2024 retrospective

China's Silk Road to Africa is not just about trade in goods -- its scope covers health, The Telegraph reports

H5N1 bird flu and mpox will be be in focus in 2025, Statnews reports

Contact Prognosis

Health questions? Have a tip that we should investigate? Contact us at AskPrognosis@bloomberg.net.

Follow Us

Like getting this newsletter? Subscribe to Bloomberg.com for unlimited access to trusted, data-driven journalism and subscriber-only insights.

Want to sponsor this newsletter?  Get in touch here.

You received this message because you are subscribed to Bloomberg's Prognosis newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices

No comments:

Post a Comment